Dixon Hubard Feinour & Brown’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $6.17M | Sell |
|
|||||
|
2022
Q1 | $5.64M | Sell |
|
|||||
|
2021
Q4 | $5.46M | Sell |
|
|||||
|
2021
Q3 | $4.57M | Sell |
|
|||||
|
2021
Q2 | $4.82M | Sell |
|
|||||
|
2021
Q1 | $7.64M | Buy |
|
|||||
|
2020
Q4 | $3.61M | Hold |
|
|||||
|
2020
Q3 | $3.61M | Sell |
|
|||||
|
2020
Q2 | $4.15M | Sell |
|
|||||
|
2020
Q1 | $3.64M | Sell |
|
|||||
|
2019
Q4 | $3.51M | Sell |
|
|||||
|
2019
Q3 | $3M | Sell |
|
|||||
|
2019
Q2 | $2.99M | Buy |
|
|||||
|
2019
Q1 | $3.44M | Buy |
|
|||||
|
2018
Q4 | $3.01M | Hold |
|
|||||
|
2018
Q3 | $2.79M | Buy |
|
|||||
|
2018
Q2 | $2.21M | Sell |
|
|||||
|
2018
Q1 | $2.06M | Sell |
|
|||||
|
2017
Q4 | $2.31M | Sell |
|
|||||
|
2017
Q3 | $2.36M | Sell |
|
|||||
|
2017
Q2 | $2.35M | Sell |
|
|||||
|
2017
Q1 | $2.46M | Sell |
|
|||||
|
2016
Q4 | $2.15M | Sell |
|
|||||
|
2016
Q3 | $2.44M | Sell |
|
|||||
|
2016
Q2 | $2.54M | Buy |
|
|||||
|
2016
Q1 | $2.42M | Sell |
|
|||||
|
2015
Q4 | $3.01M | Sell |
|
|||||
|
2015
Q3 | $3.03M | Sell |
|
|||||
|
2015
Q2 | $3.08M | Sell |
|
|||||
|
2015
Q1 | $2.76M | Buy |
|
|||||
|
2014
Q4 | $2.58M | Sell |
|
|||||
|
2014
Q3 | $2.46M | Buy |
|
|||||
|
2014
Q2 | $1.77M | Buy |
|
|||||
|
2014
Q1 | $1.55M | Sell |
|
|||||
|
2013
Q4 | $1.41M | Sell |
|
|||||
|
2013
Q3 | $1.46M | Sell |
|
|||||
|
2013
Q2 | $1.45M | Buy |
|